Rein Therapeutics Inc (RNTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,904 | -12,323 | -5,501 | -62,883 | -21,902 |
| Depreciation Amortization | 1 | 1 | N/A | 37,063 | 63 |
| Income taxes - deferred | N/A | N/A | N/A | -1,554 | N/A |
| Accounts payable and accrued liabilities | 3,212 | 5,117 | 238 | -279 | -111 |
| Other Working Capital | -605 | -791 | -938 | 3,966 | 3,376 |
| Other Operating Activity | -845 | -4,597 | 26 | 1,396 | 1,095 |
| Operating Cash Flow | $-16,141 | $-12,593 | $-6,175 | $-22,291 | $-17,479 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 5,450 | 5,450 | 738 | 17,818 | 17,817 |
| Other Financing Activity | 1,900 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $7,350 | $5,450 | $738 | $17,818 | $17,817 |
| Exchange Rate Effect | -26 | N/A | N/A | N/A | 1 |
| Beginning Cash Position | 12,865 | 12,865 | 12,865 | 17,338 | 17,338 |
| End Cash Position | 4,048 | 5,722 | 7,428 | 12,865 | 17,677 |
| Net Cash Flow | $-8,817 | $-7,143 | $-5,437 | $-4,473 | $339 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,141 | -12,593 | -6,175 | -22,291 | -17,479 |
| Free Cash Flow | -16,141 | -12,593 | -6,175 | -22,291 | -17,479 |